BELLUS Health Inc. (NASDAQ: BLU)
Some price data may be temporarily unavailable.
BELLUS Health Inc. Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
BELLUS Health Inc. Company Info
BELLUS Health Inc.
News & Analysis
Featured Article
Why Shares of Bellus Health Skyrocketed This Week
The company has received a buyout offer from GSK.
Jim Halley | Apr 20, 2023
Featured Article
Why BELLUS Health Stock Is Rocketing Higher Today
A $2 billion buyout agreement with GSK is lighting a fire under the biotech's stock today.
George Budwell | Apr 18, 2023
Why BELLUS Health Stock Fell Today
Alex Carchidi | Jul 14, 2022
Issuing new shares will leave it with plenty of money in the bank.
Here's Why Bellus Health Is Jumping Higher Today
Cory Renauer | Dec 13, 2021
A phase 2 trial with the company's chronic-cough candidate hit its primary endpoint.
Why Bellus Health Stock Tanked 69.2% Today
Todd Campbell | Jul 6, 2020
The company's lead drug has failed a phase 2 trial.
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.